NEW YORK (GenomeWeb News) – Gamma-Dynacare Medical Laboratories announced today the completion of its acquisition of a controlling interest in Impact Genetics.
Terms of the purchase were not disclosed.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Cell this week: biobank of colorectal cancer organoids, ancient wolf genome analysis, and more.
With cloud computing becoming more attractive to researchers, Nature News offers some tips on how to get going.
In a series of articles, medical journals debate the necessity of conflict-of-interest policies.
Irwin Rose, who won the 2004 Nobel Prize in Chemistry for his work on ubiquitin-mediated protein degradation, has died.